Showing results (11-20 of 42) with videos related to

Sort By:
Pageof 5
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1985
Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretionJ H Lin, K C Yeh, D E Duggan
Journal of Pharmaceutical Sciences|April 1, 1977
Radioimmunoassay of indomethacin in biological fluidsL E Hare, C A Ditzler, D E Duggan
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1985
Dose-dependent pharmacokinetics of diflunisal in rats: dual effects of protein binding and metabolismJ H Lin, K F Hooke, K C Yeh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 1, 1986
Comparative effects of H2-receptor antagonists on drug interaction in ratsJ H Lin, D M Cocchetto, K C Yeh, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1990
Biotransformation of lovastatin. II. In vitro metabolism by rat and mouse liver microsomes and involvement of cytochrome P-450 in dehydrogenation of lovastatinK P Vyas, P H Kari, S R Prakash, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1988
Kinetic studies on the competition between famotidine and cimetidine in rats. Evidence of multiple renal secretory systems for organic cationsJ H Lin, L E Los, E H Ulm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 1, 1988
Differential renal handling of angiotensin-converting enzyme inhibitors enalaprilat and lisinopril in ratsJ H Lin, I W Chen, E H Ulm, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 1, 1991
Physiological disposition of alendronate, a potent anti-osteolytic bisphosphonate, in laboratory animalsJ H Lin, D E Duggan, I W Chen, et al.
Pageof 5